Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia.
Khoshiwal AM, Frei NF, Pouw RE; TissueCypher SURF LGD Study Pathologists Consortium; Smolko C, Arora M, Siegel JJ, Duits LC, Critchley-Thorne RJ, Bergman JJGHM. Khoshiwal AM, et al. Among authors: siegel jj. Gastroenterology. 2023 Nov;165(5):1168-1179.e6. doi: 10.1053/j.gastro.2023.07.029. Epub 2023 Aug 30. Gastroenterology. 2023. PMID: 37657759 Free article. Clinical Trial.
An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
Duits LC, Khoshiwal AM, Frei NF, Pouw RE, Smolko C, Arora M, Siegel JJ, Critchley-Thorne RJ, Bergman JJGHM; Barrett's SURF LGD Study Pathologists Consortium. Duits LC, et al. Among authors: siegel jj. Am J Gastroenterol. 2023 Nov 1;118(11):2025-2032. doi: 10.14309/ajg.0000000000002363. Epub 2023 Jun 13. Am J Gastroenterol. 2023. PMID: 37307529 Free PMC article.
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Hooper PB, Farberg AS, Fitzgerald AL, Siegel JJ, Rackley BB, Prasai A, Kurley SJ, Goldberg MS, Litchman GH. Hooper PB, et al. Among authors: siegel jj. Cancer Invest. 2022 Nov;40(10):911-922. doi: 10.1080/07357907.2022.2116454. Epub 2022 Sep 15. Cancer Invest. 2022. PMID: 36073945
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
Ibrahim SF, Kasprzak JM, Hall MA, Fitzgerald AL, Siegel JJ, Kurley SJ, Covington KR, Goldberg MS, Farberg AS, Trotter SC, Reed K, Brodland DG, Koyfman SA, Somani AK, Arron ST, Wysong A. Ibrahim SF, et al. Among authors: siegel jj. Future Oncol. 2022 Mar;18(7):833-847. doi: 10.2217/fon-2021-1277. Epub 2021 Nov 25. Future Oncol. 2022. PMID: 34821148 Free article.
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Wysong A, Somani AK, Ibrahim SF, Cañueto J, Fitzgerald AL, Siegel JJ, Prasai A, Goldberg MS, Farberg AS, Regula C, Bar A, Kasprzak J, Brodland DG, Koyfman SA, Arron ST. Wysong A, et al. Among authors: siegel jj. Dermatol Ther (Heidelb). 2024 Mar;14(3):593-612. doi: 10.1007/s13555-024-01111-5. Epub 2024 Mar 1. Dermatol Ther (Heidelb). 2024. PMID: 38424384 Free PMC article.
46 results